CRISPR-Cas9 System: Opportunities and Concerns

Affiliations

• ¹ Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada; Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada;
• ² Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada; Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada; Department of Clinical Biochemistry, University Health Network, Toronto, Ontario, Canada; ediamandis@mtsinai.on.ca.
• ³ Professor of Genetics, Department of Genetics, Harvard Medical School, Boston, MA; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA;
• ⁴ Center for Law and the Biosciences, Stanford University, Stanford, CA;
• ⁵ Professor, Canada Research Chair in Bioethics and Philosophy, Novel Tech Ethics, Faculty of Medicine, Dalhousie University, Halifax, Canada;
• ⁶ Chancellor's Professor and Chair, Department of Gender and Women's Studies and the Center for Science, Technology, Medicine, and Society, University of California, Berkeley, CA; RQIF Professor, Department of Sociology, London School of Economics, London, UK;
• ⁷ Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada; Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada.